Atai life sciences announces first subject dosed in phase 1 trial of buccal and iv vls-01, a synthetic form of dmt

- atai has dosed the first subject in their phase 1 single-ascending dose (sad) trial of vls-01 with topline results expected in h1 2023.
ATAI Ratings Summary
ATAI Quant Ranking